Pre-market trading concluded on June 2nd, with the highly anticipated new stock Shougang Lanza (02553) delivering a debut performance that far exceeded expectations. Market sentiment had been divided, with some concerns about concentrated selling pressure from successful allotments, while others remained bullish on its potential in AI synthetic biology, exclusive CCUS credentials, and the trillion-dollar SAF market.
Amid this tug-of-war, the stock saw frenzied buying from the opening of pre-market trading, with its price surging to a high of HK$43, representing a massive 194.52% increase over its IPO price of HK$14.6. It ultimately settled at HK$36, up 146.58%, with a turnover of HK$194 million. Shougang Lanza is scheduled for its official listing on the Hong Kong Stock Exchange on June 3rd.
During the pre-market session, gains approached 200% at one point. By the close, buy orders accounted for a dominant 97.14% of the trading interest, indicating that most immediate selling pressure had been absorbed. The structure of capital flows shows that the over 1,400-times oversubscription in the public offering had already accumulated a significant pool of sidelined capital. The strong pre-market performance further catalyzed buying sentiment, suggesting ample potential buying power remains in reserve.
Following the substantial turnover in the pre-market session, most short-term arbitrage positions have likely exited, leading to a notable optimization of the shareholder structure. From a fundamental perspective, the company operates across several high-potential sectors including ESG, synthetic biology, CCUS, AI-driven manufacturing, and SAF, providing a solid value foundation.
Shougang Lanza specializes in the resource utilization of industrial waste gases, converting exhaust gases from industries like steel and ferroalloys into products such as ethanol and microbial protein through biological fermentation. It is the world's first company to achieve large-scale commercial application of this technological pathway and has completed the transition from first-generation carbon reduction to second-generation carbon-negative solutions.
The company also holds a forward-looking position in the SAF sector, with plans to commission China's first 50,000-ton demonstration project by 2027. Backed by the state-owned assets of its parent, Shougang Group, and holding China's first license for synthesizing feed protein from industrial waste gas, the company enjoys significant advantages in its cost curve and competitive barriers.
Overall, the strong finish in pre-market trading sets a positive tone for tomorrow's official debut, with a high probability of initial volatile but upward movement. In the medium to long term, the company is strategically aligned with two major global trends: carbon reduction and food security, providing sustainable support for both valuation re-rating and growth narratives.
Comments